fuchs uveitis syndrome

Reading File
Finding Sources
Searching PubMed

"Fuchs uveitis syndrome" OR "Fuchs heterochromic iridocyclitis"

Reading File
Finding Sources
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have comprehensive content. Let me compile the full answer.

Fuchs Uveitis Syndrome (FUS)

Also called Fuchs heterochromic iridocyclitis (FHC) or Fuchs heterochromic cyclitis. A classic and well-characterised chronic anterior uveitis entity.

Overview

  • Type: Chronic, non-granulomatous anterior uveitis
  • Age at diagnosis: Average ~40 years
  • Sex/race: No predilection
  • Laterality: Unilateral in 90-95% of cases
  • Etiology: Uncertain. Strongest evidence implicates rubella virus. Toxoplasma gondii has also been suspected. Much of the apparent "anterior chamber (AC) activity" may be due to blood-aqueous barrier breakdown rather than true inflammation.

Clinical Features

Symptoms

  • Often detected incidentally
  • Gradual visual blurring (due to cataract development)
  • Persistent floaters
  • Patient or clinician may notice heterochromia

Signs (the "FUS constellation")

1. Heterochromia iridis
  • Most effectively seen in daylight
  • Typically the affected eye is hypochromic (lighter) - Fig. A below
  • Due to diffuse iris stromal atrophy + posterior pigment epithelial atrophy
  • Exception: in blue eyes, stromal atrophy allows the pigmented posterior layer to dominate, making the eye paradoxically hyperchromic
Fig. 12.13A - Right eye involvement showing hypochromia (lighter right iris vs. darker left)
2. Keratic precipitates (KPs)
  • Characteristically stellate, grey-white
  • Located diffusely over the entire corneal endothelium (not just inferior as in typical uveitis)
  • This diffuse stellate distribution is pathognomonic
Fig. 12.13B - Diffuse stellate keratic precipitates distributed across entire endothelium
3. Iris nodules
  • Koeppe nodules (on pupillary border) - present in ~30% - arrow shown in Fig. C
  • Russell bodies (tiny crystals) may be present on iris surface
Fig. 12.13C - Koeppe nodules (arrow) at pupillary border with iris atrophy and loss of stromal architecture
4. Iris atrophy
  • Diffuse with loss of crypts
  • Iris appears smooth with a prominent sphincter pupillae
  • Pigment epithelial atrophy demonstrated by retroillumination (band-like pattern)
  • Fine irregular iris surface vessels commonly present
5. Anterior chamber
  • Faint flare, usually only mild cellular activity
  • The eye is virtually always white even during exacerbations - no ciliary injection
  • No posterior synechiae (PS) - absence of PS is a distinguishing feature (may appear post-surgery)
6. Vitritis
  • Anterior vitreous opacities may be dense
7. Posterior subcapsular cataract
  • Extremely common - a frequent mode of presentation
8. Glaucoma
  • A later manifestation, but occasionally present at diagnosis
  • Develops in up to 60% of involved eyes
  • Multiple mechanisms suspected
9. Gonioscopy
  • Fine radial angle vessels or small irregular peripheral anterior synechiae (PAS)
  • These angle vessels are the source of the Amsler sign - a small hyphema that appears on paracentesis / AC incision due to bleeding from fragile neovascular angle vessels
10. Fundus
  • Peripheral choroiditis foci/scarring reported
  • Possible increased incidence of retinal dialysis
  • Macular edema does not occur except following surgery (a key differentiator)

Heterochromia Iridis - Differential Diagnosis

TypeCauses
Hypochromic (lighter)Idiopathic congenital, Horner syndrome (especially congenital), Waardenburg syndrome
Hyperchromic (darker)Topical prostaglandin analogue use, oculodermal melanocytosis (naevus of Ota), ocular siderosis, diffuse iris naevus/melanoma, Sturge-Weber syndrome
EitherFuchs uveitis syndrome, other chronic anterior uveitides

Investigation

Diagnosis is clinical. Investigation is needed only to exclude alternative conditions (e.g., herpetic uveitis, sarcoidosis, toxoplasmosis).

Treatment

ProblemManagement
Chronic low-grade inflammationTopical steroids generally NOT helpful long-term; may be used short-term for moderate/severe exacerbations
MonitoringLong-term monitoring for glaucoma and cataract is mandatory
Cataract surgeryCarries increased risk: poor mydriasis, postoperative hyphema, increased inflammation, worsened glaucoma, zonular dehiscence. Preoperative topical/systemic steroids used by some
GlaucomaOften difficult to control medically; surgical options include glaucoma drainage device or trabeculectomy + mitomycin-C
Vitreous opacificationPars plana vitrectomy may be considered for visually significant cases

Key Points for Exam / Clinic

  • FUS is almost always unilateral, presents in middle age, no sex preference
  • The eye is white and quiet-looking despite active inflammation
  • No posterior synechiae (absence is hallmark - unlike most other anterior uveitides)
  • KPs are diffuse and stellate (not inferior/mutton-fat)
  • Amsler sign - bleeding from angle vessels during paracentesis
  • Macular edema absent (except post-op)
  • Rubella virus is the leading suspected etiology
  • Glaucoma develops in up to 60% - the most significant long-term complication
  • Steroids do NOT prevent progression and are not used chronically

Source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th edition, p. 459-460
This is a shared conversation. Sign in to Orris to start your own chat.